FdaApplication
ANDA 209597
Identifiers
- fda_app_no: ANDA209597
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2021-03-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHOLESTYRAMINE | CHOLESTYRAMINE | EQ 4GM RESIN/PACKET | POWDER;ORAL |
| CHOLESTYRAMINE | CHOLESTYRAMINE | EQ 4GM RESIN/SCOOPFUL | POWDER;ORAL |
2 products